attachment
attachment
attachment

Explain visually

Reading File
Searching Images

aminoglycoside mechanism of action ribosome protein synthesis

Searching Images

aminoglycoside transport bacterial cell membrane

Loading Image
Here is a full visual breakdown of Chapter 54 — Aminoglycoside Antibiotics:

🦠 What Are Aminoglycosides?

Natural and semi-synthetic antibiotics with polybasic amino groups linked to aminosugar residues. All produced by soil actinomycetes.
CategoryMembers
SystemicStreptomycin, Gentamicin, Kanamycin, Tobramycin, Amikacin, Sisomicin, Netilmicin, Paromomycin
TopicalNeomycin, Framycetin

⚙️ Mechanism of Action — Two Steps

Aminoglycoside ribosome mechanism diagram

Step 1 — Entry into the bacterial cell (multistep transport)

Outer coat (porin channels)
        ↓
Periplasmic space
        ↓  ← carrier-mediated, linked to electron transport chain
Cytoplasmic membrane  ←  Energy-Dependent Phase I (EDP₁)
        ↓
Inside cell
Why anaerobes are resistant: The carrier system is oxygen-dependent. Without O₂, the membrane is not polarized → drug can't get in. This also explains why abscesses (low O₂) reduce efficacy.
Why alkaline pH helps: Aminoglycosides are ~20× more active at alkaline pH. β-lactams and vancomycin (cell-wall agents) enhance entry by disrupting the outer barrier.

Step 2 — Ribosome binding → Protein synthesis inhibition

Aminoglycosides bind 30S ribosome (streptomycin) and also 50S subunit & 30S–50S interface (other members):
EffectConsequence
A Block initiation complexProtein synthesis never starts
B Inhibit tRNA translocation (A→P site)Elongation stops
C Distort mRNA codon recognitionWrong amino acids incorporated → defective/toxic proteins
These defective proteins insert into the cell membrane → membrane becomes permeable → ions, amino acids, proteins leak out → cell death (bactericidal, not just static).
This also triggers EDP₂ (Energy-Dependent Phase II) — more drug enters, reinforcing the lethal cycle.

🛡️ Mechanism of Resistance

3 Mechanisms:

1. Modifying enzymes (most important)
   ├─ Phosphorylate, adenylate, or acetylate the drug
   ├─ Modified drug can't bind ribosomes
   └─ Encoded in plasmids → spread between bacteria

2. Ribosomal mutation
   └─ Reduced affinity of ribosomal proteins → partial resistance

3. Decreased transport
   ├─ Outer coat porin channels become less permeable
   └─ Active transport interfered → drug can't reach ribosome
Cross-resistance among aminoglycosides is variable (depends on which enzymes are present).

☠️ Shared Toxicities

Table 54.1 — Comparative Toxicity

DrugVestibular ToxicityCochlear ToxicityNephrotoxicity
Streptomycin++ (high)± (low)+
Gentamicin++ (high)++
Kanamycin+++ (high)++
Tobramycin+++
Amikacin+
Sisomicin+
Netilmicin+

1. 🔊 Ototoxicity (most important adverse effect)

Drug concentrates in labyrinthine fluid → slowly removed when plasma falls

↑ Plasma trough > threshold → concentration-dependent toxicity

For Gentamicin:
  Trough > 2 μg/ml → vestibular damage (concentration-dependent)
  Target trough < 1 μg/ml to avoid toxicity
Cochlear damage:
  • Starts at base (high frequencies) → spreads to apex (low frequencies)
  • Tinnitus → progressive hearing loss
  • Sensory cells do NOT regenerate → damage is permanent
  • Kanamycin & Amikacin = worst cochlear toxicity
Vestibular damage:
  • Headache → nausea → dizziness → nystagmus → vertigo → ataxia
  • Stop drug: enters chronic phase (6–10 weeks asymptomatic lying down, difficulty walking)
  • Recovery over 1–2 years — often incomplete; elderly recover poorly
  • Streptomycin & Gentamicin = worst vestibular toxicity

2. 🫘 Nephrotoxicity

Drug → high concentration in renal cortex (proximal tubules)
     ↓
Tubular damage → ↓ urinary concentrating power
     ↓
↓ GFR, nitrogen retention, albuminuria, casts
     ↓
↓ Drug clearance → ↑ blood levels → ↑ ototoxicity
  • Single daily dosing causes less nephrotoxicity than thrice-daily dosing
  • Worse in: elderly, pre-existing kidney disease
  • If drug is stopped promptly → reversible
  • Streptomycin = least nephrotoxic

3. 🧠 Neuromuscular Blockade

All aminoglycosides reduce ACh release at motor nerve endings by:
  • Blocking synaptic vesicle fusion with terminal membrane (antagonize Ca²⁺)
  • Reducing muscle end-plate sensitivity to ACh
Clinically silent usually, but apnoea and fatalities can occur if drug is put into peritoneal/pleural cavity after surgery (especially with curare-type muscle relaxants). Partially reversed by IV calcium salt. Myasthenic weakness is worsened.

⚠️ Precautions & Interactions

PrecautionReason
Avoid in pregnancyFoetal ototoxicity
Avoid with NSAIDs, amphotericin B, vancomycin, cyclosporine, cisplatinAdditive nephrotoxicity
Caution with vancomycin, minocycline, furosemidePotentially additive ototoxicity
Caution in patients >60 yrs or kidney diseaseReduced clearance, higher toxicity risk

🔑 Common Properties (Memory Summary)

S-I-B-B-A-P-C-N-O
  1. Sulfate salts — highly water-soluble, stable for months
  2. Ionize in solution — not absorbed orally; no CNS/CSF penetration
  3. Bactericidal — more active at alkaline pH
  4. Bacteria targeted — aerobic gram-negative bacilli (not anaerobes)
  5. All excreted unchanged by glomerular filtration
  6. Partial cross-resistance only
  7. Concentration-distributed extracellularly only
  8. Narrow margin of safety
  9. Ototoxicity + nephrotoxicity in all members
This is a shared conversation. Sign in to Orris to start your own chat.